Legend: : Special Mention  : Important : Very Important : Key Development |
| |
 |
Rapid detection of Opisthorchis viverrini and Strongyloides stercoralis in human fecal samples using a duplex real-time PCR and melting curve analysis.
Janwan P, Intapan PM, Thanchomnang T, Lulitanond V, Anamnart W, Maleewong W., Parasitol Res. 2011 May 3. [Epub ahead of print] |
 |
High throughput multiplex PCR and probe-based detection with Luminex beads forseven intestinal parasites.
Taniuchi M, Verweij JJ, Noor Z, Sobuz SU, Lieshout L, Petri WA Jr, Haque R, HouptER., Am J Trop Med Hyg. 2011 Feb;84(2):332-7. |
| |
A pentaplex real-time polymerase chain reaction assay for detection of fourspecies of soil-transmitted helminths.
Basuni M, Muhi J, Othman N, Verweij JJ, Ahmad M, Miswan N, Rahumatullah A, AzizFA, Zainudin NS, Noordin R., Am J Trop Med Hyg. 2011 Feb;84(2):338-43. |
| |
Strongyloides stercoralis: there but not seen.
Montes M, Sawhney C, Barros N., Curr Opin Infect Dis. 2010 Oct;23(5):500-4. |
| |
Hydrophobic fractions from Strongyloides venezuelensis for use in the humanimmunodiagnosis of strongyloidiasis.
Feliciano ND, Gonzaga HT, Gonçalves-Pires Mdo R, Gonçalves AL, Rodrigues RM, UetaMT, Costa-Cruz JM., Diagn Microbiol Infect Dis. 2010 Jun;67(2):153-61. Epub 2010 Mar 31. |
| |
Vaccination against Strongyloides venezuelensis with homologue antigens using newimmunomodulators.
Vlaminck J, López-Abán J, Ruano AL, del Olmo E, Muro A., J Parasitol. 2010 Jun;96(3):643-7. |
| |
Molecular identification of the causative agent of human strongyloidiasisacquired in Tanzania: dispersal and diversity of Strongyloides spp. and theirhosts.
Hasegawa H, Sato H, Fujita S, Nguema PP, Nobusue K, Miyagi K, Kooriyama T,Takenoshita Y, Noda S, Sato A, Morimoto A, Ikeda Y, Nishida T., Parasitol Int. 2010 Sep;59(3):407-13. Epub 2010 Jun 4. |
 |
Strongyloidiasis--the most neglected of the neglected tropical diseases?
Olsen A, van Lieshout L, Marti H, Polderman T, Polman K, Steinmann P, Stothard R, Thybo S, Verweij JJ, Magnussen P, Trans R Soc Trop Med Hyg. 2009 Oct;103(10):967-72 |
| |
A luciferase immunoprecipitation systems assay enhances the sensitivity and specificity of diagnosis of Strongyloides stercoralis infection.
Ramanathan R, Burbelo PD, Groot S, Iadarola MJ, Neva FA, Nutman TB, J Infect Dis. 2008 Aug 1;198(3):444-51 |
| |
DNA immunization with Na+-K+ ATPase (Sseat-6) induces protective immunity to larval Strongyloides stercoralis in mice.
LA Kerepesi, PB Keiser, TJ Nolan, GA Schad, D Abraham, TB Nutman, Infect Immun. 2005 Apr:2298-305 |
| |
Colonoscopic findings and pathologic characteristics of Strongyloides colitis: a case series.
Minematsu H, Hokama A, Makishi T, Arakaki K, Kinjo F, Fujita J., Digestion. 2011;83(3):210-4. Epub 2011 Jan 21. |
| |
Disseminated Strongyloides stercoralis: hyperinfection during medicalimmunosuppression.
Basile A, Simzar S, Bentow J, Antelo F, Shitabata P, Peng SK, Craft N., J Am Acad Dermatol. 2010 Nov;63(5):896-902. Epub 2010 Feb 20. |
| |
Detergent fraction of heterologous antigen to detect IgA and IgG instrongyloidiasis using saliva and serum paired samples.
Ribeiro VS, Feliciano ND, Gonzaga HT, Costa IN, Gonçalves-Pires MR, Ueta MT,Costa-Cruz JM., Immunol Lett. 2010 Nov 30;134(1):69-74. Epub 2010 Sep 15. |
| |
Albendazole stimulates the excretion of strongyloides stercoralis Larvae in stoolspecimens and enhances sensitivity for diagnosis of strongyloidiasis.
Anamnart W, Pattanawongsa A, Intapan PM, Maleewong W., J Clin Microbiol. 2010 Nov;48(11):4216-20. Epub 2010 Sep 15. |
| |
Field survey for strongyloidiasis in eastern Uganda with observations on efficacyof preventive chemotherapy and co-occurrence of soil-transmittedhelminthiasis/intestinal schistosomiasis.
Sousa-Figueiredo JC, Day M, Betson M, Rowell C, Wamboko A, Arinaitwe M, KazibweF, Kabatereine NB, Stothard JR., J Helminthol. 2010 Oct 20:1-9. [Epub ahead of print] |
| |
Duodenal obstruction - an unusual presentation of Strongyloides stercoralisenteritis: a case report.
Cruz RJ Jr, Vincenzi R, Ketzer BM., World J Emerg Surg. 2010 Aug 10;5:23. |
| |
High rate of strongyloidosis infection, out of endemic area, in patients witheosinophilia and without risk of exogenous reinfections.
Repetto SA, Durán PA, Lasala MB, González-Cappa SM., Am J Trop Med Hyg. 2010 Jun;82(6):1088-93. |
| |
Factors affecting recovery of Strongyloides stercoralis larvae: an approach to a newly modified formalin-ether concentration technique for diagnosis ofstrongyloidiasis.
Anamnart W, Pattanawongsa A, Intapan PM, Maleewong W., J Clin Microbiol. 2010 Jan;48(1):97-100. Epub 2009 Nov 18. |
| |
Intestinal strongyloidiasis: a diagnosis frequently missed in the tropics.
Agrawal V, Agarwal T, Ghoshal UC, Trans R Soc Trop Med Hyg. 2009 Mar;103(3):242-6 |
| |
The Strongyloides (Nematoda) of sheep and the predominant Strongyloides of cattle form at least two different, genetically isolated populations.
Eberhardt AG, Mayer WE, Bonfoh B, Streit A, Vet Parasitol. 2008 Oct 20;157(1-2):89-99 |
| |
Association of a sex-related difference of Strongyloides stercoralis-specific IgG4 antibody titer with the efficacy of treatment of strongyloidiasis.
M Satoh, H Toma, S Kiyuna, Y Shiroma, A Kokaze, Y Sato, Am J Trop Med Hyg. 2004 Jul:107-11 |
| |
Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
EM Carvalho, A Da Fonseca Porto, Parasite Immunol. 2004 Nov-Dec:487-97 |
| |
Intestinal damage in strongyloidiasis: the imbalance between cell death and proliferation.
AL Werneck-Silva, EP Alvares, P Gama, AO Damião, LH Osaki, D Ogias, AM Sipahi, Dig Dis Sci. 2006 Jun:1063-9 |
| |
Severe and treatment resistant strongyloidiasis--indicator of HTLV-I infection.
Jeyamani R, Joseph AJ, Chacko A, Trop Gastroenterol. 2007 Oct-Dec;28(4):176-7 |
| Supplementary evidence: |
| |
Factors affecting recovery of Strongyloides stercoralis larvae: an approach to a newly modified formalin-ether concentration technique for diagnosis of strongyloidiasis.
Anamnart W, Pattanawongsa A, Intapan PM, Maleewong W, J Clin Microbiol. 2010 Jan;48(1):97-100 |
| |
An in vitro larval motility assay to determine anthelmintic sensitivity for human hookworm and Strongyloides species.
AC Kotze, S Clifford, J O'Grady, JM Behnke, JS McCarthy, Am J Trop Med Hyg. 2004 Nov:608-16 |
| |
Comparison of anthelmintic effects of two doses of ivermectin on intestinal strongyloidiasis in patients negative or positive for anti-HTLV-1 antibody.
O Zaha, T Hirata, N Uchima, F Kinjo, A Saito, J Infect Chemother. 2004 Dec:348-51 |
| |
Comparison of enzyme-linked immunosorbent assay and indirect immunofluorescence assay in the diagnosis of human strongyloidiasis.
S Koosha, M Fesharaki, MB Rokni, Indian J Gastroenterol. 2004 Nov-Dec:214-6 |
| |
Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management.
S Lim, K Katz, S Krajden, M Fuksa, JS Keystone, KC Kain, CMAJ. 2004 Aug 31:479-84 |
| |
Displaced bacterial colonies indicating Strongyloides larval migration on agar plates.
MR Mariappan, O Vielemeyer, O Fadare, S Paventy, FJ Bia, Arch Pathol Lab Med. 2004 Jun:711-2 |
| |
Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda.
M Brown, M Kizza, C Watera, MA Quigley, S Rowland, P Hughes, JA Whitworth, AM Elliott, J Infect Dis. 2004 Nov 15:1869-79 |
| |
Helminthic infection down-regulates type 1 immune responses in human T cell lymphotropic virus type 1 (HTLV-1) carriers and is more prevalent in HTLV-1 carriers than in patients with HTLV-1-associated
AF Porto, SB Santos, AL Muniz, V Basilio, W Rodrigues Jr, FA Neva, WO Dutra, KJ Gollob, S Jacobson, EM Carvalho, J Infect Dis. 2005 Feb 15:612-8 |
| |
Soil-transmitted helminthiases and health behaviors among schoolchildren and community members in a west-central border area of Thailand.
MT Anantaphruti, J Waikagul, W Maipanich, S Nuamtanong, S Pubampen, Southeast Asian J Trop Med Public Health. 2004 Jun:260-6 |
| |
Strongyloides hyperinfection syndrome after heart transplantation: case report and review of the literature.
MW Schaeffer, JF Buell, M Gupta, GD Conway, SA Akhter, LE Wagoner, J Heart Lung Transplant. 2004 Jul:905-11 |
| |
Strongyloides stercoralis in the Immunocompromised Population.
PB Keiser, TB Nutman, Clin Microbiol Rev. 2004 Jan:208-17 |
| |
Strongyloides stercoralis infection as a manifestation of immune restoration syndrome.
AC Kim, HC Lupatkin, Clin Infect Dis. 2004 Aug 1:439-40 |
| |
Strongyloidiasis in children five years and below.
HO Dada-Adegbola, RA Bakare, West Afr J Med. 2004 Jul-Sep:194-7 |
| |
Strongyloidiasis.
K Asano, S Tada, T Kamio, T Matsumoto, H Suko, M Iida, Gastrointest Endosc. 2004 Oct:606-7 |
| |
Successful ivermectin treatment of hepatic strongyloidiasis presenting with severe eosinophilia.
Z Gulbas, M Kebapci, O Pasaoglu, E Vardareli, South Med J. 2004 Sep:907-10 |
| |
The amphidial neuron pair ALD controls the temperature-sensitive choice of alternative developmental pathways in the parasitic nematode, Strongyloides stercoralis.
TJ Nolan, M Brenes, FT Ashton, X Zhu, WM Forbes, R Boston, GA Schad, Parasitology. 2004 Dec:753-9 |
| |
The cost-effectiveness of ivermectin vs. albendazole in the presumptive treatment of strongyloidiasis in immigrants to the United States.
P Muennig, D Pallin, C Challah, K Khan, Epidemiol Infect. 2004 Dec:1055-63 |
| |
The spectrum of GI strongyloidiasis: an endoscopic-pathologic study.
BF Thompson, LC Fry, CD Wells, M Olmos, DH Lee, AJ Lazenby, KE M&oeig;nkemuller, Gastrointest Endosc. 2004 Jun:906-10 |
| |
Treatment strategies in controlling strongyloidiasis.
M Satoh, A Kokaze, Expert Opin Pharmacother. 2004 Nov:2293-301 |
| |
Why does HIV infection not lead to disseminated strongyloidiasis?
ME Viney, M Brown, NE Omoding, JW Bailey, MP Gardner, E Roberts, D Morgan, AM Elliott, JA Whitworth, J Infect Dis. 2004 Dec 15:2175-80 |